Safety and reproducibility of Nasal Allergen Challenge

Abstract

Background

The nasal allergen challenge (NAC) is a useful tool for the diagnosis of allergic rhinitis (AR) and local allergic rhinitis (LAR), and might serve to design and monitor allergen immunotherapy. Nevertheless, data about its safety and reproducibility is scarce.

Objective

To investigate the safety and reproducibility of NAC in pediatric and adult rhinitis patients with/without asthmatic symptoms, and in healthy controls.

Methods

A retrospective evaluation of the NACs conducted in our Unit for 2005‐2017 and monitored by acoustic rhinometry and nasal‐ocular symptoms was performed to analyze the safety of two methods for allergen application (metered spray & micropipette) and NAC protocols (NAC with single or multiple allergens/session (NAC‐S & NAC‐M)). The adverse events (AE), spirometry values, and rescue medication required for AE were recorded. The reproducibility was examined by a prospective analysis of three repeated NAC‐S performed at 1‐2‐month interval in AR, LAR and non‐allergic rhinitis patients, and in healthy controls.

Results

A total of 11499 NACs were performed in 518 children and 5830 adults. Only four local AE occurred, and 99.97% of NACs were well tolerated. The reproducibility and positive and negative predictive values of three consecutive NAC‐S performed in 710 subjects were 97.32%, 100%, and 92.91% respectively. There were no false positive results in the 710 analyzed subjects. Safety and reproducibility were comparable between the methods of allergen application and the rhinitis phenotypes.

Conclusion

The NAC is a safe and highly reproducible diagnostic test ready to be used in the clinical practice in both children and adults with or without asthma.

This article is protected by copyright. All rights reserved.

http://bit.ly/2R7NUmR